Vor Biopharma Inc..
VOR.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Vor Biopharma Inc. is a clinical-stage cell therapy company focused on developing engineered hematopoietic stem cells (eHSCs) to create next-generation, off-the-shelf therapies for hematological malignancies. Their lead product candidate, VOR33, is designed to address acute myeloid leukemia (AML) an...Show More
Better Health for All
0
No relevant information regarding Vor Biopharma Inc.'s performance against the 'Better Health for All' ethical value could be extracted from the provided articles. The articles either did not contain information about VOR.US, were inaccessible, or were about unrelated companies.
1
Fair Money & Economic Opportunity
0
No evidence available to assess Vor Biopharma Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
In 2024, the CEO's compensation decreased by 17.49% to $2,220,349, while the CMO's compensation decreased by 23.16% and the CSO's by 23.37%.
1
The company laid off 155 employees, effective July 15, 2025, reducing its workforce to 8 remaining employees.
2
This represents approximately 95% of the staff being laid off.
3
A Massachusetts Workers Adjustment Retraining Notice was filed in connection with these layoffs.
4
Fair Trade & Ethical Sourcing
0
No information relevant to Fair Trade & Ethical Sourcing, including fair-trade certifications, supplier audits, child/forced labour incidents, supply chain traceability, remediation speed, ethical clauses in contracts, high-risk materials, or supplier diversity spend, was found in the provided articles.
1
Honest & Fair Business
0
The provided article focuses on financial performance, operational metrics, and clinical development, including net losses, funding, employee numbers, and patent information.
1
However, it does not contain specific, quantifiable evidence for any of the KPIs related to the 'Honest & Fair Business' ethical value. Mentions of 'FCPA compliance documentation' and 'External audit opinions' are too general and lack the specific details required to map to any rubric tiers, such as policy strength, enforcement, or the extent of verification.
2
Kind to Animals
0
No specific evidence was found in the provided articles regarding Vor Biopharma Inc.'s performance against the 'Kind to Animals' ethical value. The articles discuss broader regulatory changes and market trends related to animal testing alternatives in the pharmaceutical industry, such as the FDA Modernization Act 3.0 and the growth of organ-on-a-chip and organoid markets, but they do not provide any direct, company-specific data, policies, or actions attributable to Vor Biopharma Inc. for any of the KPIs.
1
No War, No Weapons
0
Vor Biopharma Inc. has no military contracting, indicating 0% direct arms revenue and no defense or arms-related activities in its core business.
1
The company also has no controversial weapons.
2
Planet-Friendly Business
0
The provided articles, including those from Sustainalytics and Yahoo Finance, explicitly state that no quantitative data related to specific sustainability metrics such as Scope 1, 2, and 3 emissions, renewable energy usage, water consumption, waste diversion rates, or environmental compliance violations is available for Vor Biopharma Inc. was inaccessible.
1
Consequently, there is no evidence to score any of the Planet-Friendly Business KPIs.
Respect for Cultures & Communities
0
No specific, concrete data points relevant to the 'Respect for Cultures & Communities' ethical value were found in the provided articles for VOR.US. The articles focused on financial, leadership, and clinical trial information, or access to their content was unavailable.
1
Safe & Smart Tech
0
The company initiated a security awareness program using gamification and phishing simulations, which resulted in a 62% increase in user-reported phishing and a 10% reduction in simulation click rates.
1
Encryption of certain data is mentioned as a security measure.
2
Vulnerability assessments and penetration testing are also mentioned as security measures.
3
A GRC platform aligning with SOC2 and ISO 27001 security frameworks was implemented, and a company-wide information security program aligning with ISO 27001 was launched.
4
Users have options to opt-out of marketing emails and manage cookies.
5
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles for VOR.US regarding waste diversion rates, product recyclability, packaging sustainability, recycled content percentage, single-use plastic reduction, take-back program coverage, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.
1
Information provided in one article pertained to a different company, Avantor, and was not applicable to VOR.US.
2